A detailed history of Central Valley Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Central Valley Advisors, LLC holds 5,124 shares of JNJ stock, worth $794,424. This represents 0.47% of its overall portfolio holdings.

Number of Shares
5,124
Previous 5,236 2.14%
Holding current value
$794,424
Previous $766 Million 8.42%
% of portfolio
0.47%
Previous 0.33%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$145.48 - $167.38 $16,293 - $18,746
-112 Reduced 2.14%
5,124 $830 Million
Q2 2024

Jul 12, 2024

SELL
$144.38 - $157.78 $38,116 - $41,653
-264 Reduced 4.8%
5,236 $766 Million
Q1 2024

Apr 12, 2024

SELL
$155.22 - $162.74 $35,700 - $37,430
-230 Reduced 4.01%
5,500 $870 Million
Q4 2023

Feb 09, 2024

BUY
$145.6 - $158.88 $834,288 - $910,382
5,730 New
5,730 $898 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Central Valley Advisors, LLC Portfolio

Follow Central Valley Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Valley Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Central Valley Advisors, LLC with notifications on news.